✦ LIBER ✦

A115 Amifostine to Reduce the Toxicity of Outpatient ASCT in Multiple Myeloma

✍ Scribed by Scortechini, I; Montanari, M; Capelli, D; Inglese, E; Offidani, M; Poloni, A; Gini, G; Mancini, G; Trappolini, S; Leoni, P

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ASCT in a young patient with features of

✍ W. Roesler; A. Guenther; N. Schub; J. Winkler; A. Rascu; R. Repp; M. Gramatzki 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Use of amifostine (AMI) to reduce toxici

✍ Bafaloukos, D.; Samelis, G.; Mela, A.; Aravantinos, G.; Xiros, N.; Dimou, M.; Ka 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Factors Influencing the Outcome of a Sec

✍ Gordon Cook; Effie Liakopoulou; Rachel Pearce; Jim Cavet; Gareth J. Morgan; Keir 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 400 KB

A different schedule of zoledronic acid

✍ Corso, A; Varettoni, M; Zappasodi, P; Klersy, C; Mangiacavalli, S; Pica, G; Lazz 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Relapsed multiple myeloma in the UK prio

✍ JOHN QUINN; FRAN PERCIVAL; MARTIN AUGER; SUPRATIK BASU; PATRICK CHU; MAADH ALDOU 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

A plea to overcome the concept of “stagi

✍ Paolo G. Gobbi; Daniele Bertoloni; Giovanni Grignani; Carla Pieresca; Andrea Ros 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB